Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Robert Bazemore Insider Profile

11 Followers

Robert Bazemore, Director at Akari Therapeutics, holds 22.76K shares in Akari Therapeutics (Ticker: AKTX), holds 68.01K shares in Ardelyx (Ticker: ARDX), holds 5.00K shares in Nuvation Bio (Ticker: NUVB).

Robert Bazemore's Trading History

AKTXAkari Therapeutics		Oct 16, 2026DirectorUninformative Buy168.41K$187.53K
ARDXArdelyx		Jun 18, 2026DirectorUninformative Buy―$206.06K
NUVBNuvation Bio		Apr 01, 2021DirectorInformative Buy49.85K$23.80K
EPZMEpizyme		Mar 29, 2021―Uninformative Sell81.07K$474.26K
GEVASynageva		Jun 23, 2015―Uninformative Sell――
NTGNNeon Therapeutics		――――
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Robert Bazemore insider profile FAQ

What stocks does Robert Bazemore hold?
Robert Bazemore holds: AKTX, GEVA, ARDX, NTGN, NUVB, EPZM stocks.
What was Robert Bazemore’s latest transaction?
Robert Bazemore’s latest transaction was an Uninformative Buy of $168.41K.
What is Robert Bazemore's role in Akari Therapeutics?
Robert Bazemore's role in Akari Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.